跳至主要内容
临床试验/EUCTR2016-003347-10-FI
EUCTR2016-003347-10-FI进行中(未招募)1 期

The effects of PXR activation on HDL-cholesterol

Oulu University Hospital, Internal Medicine Research Unit0 个研究点目标入组 24 人开始时间: 2016年12月5日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Healthy volunteers
  • 18-40 years of age
  • Body mass index (BMI) 18.5-30 kg/m2
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 24
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Systolic pressure more than 150 mmHg
  • Any continuous medication (including birth control pills; hormonal intrauterine device, inhaled asthma medications, and topical treatments for skin diseases are permitted)
  • Any significant medical condition including any liver disease
  • Insensitivity to rifampicin
  • Pregnancy and breast feeding
  • History of difficult venipuncture
  • Alcohol and medicine abuse and drug use
  • Participation in any other pharmaceutical trial within one month of screening

研究者

发起方
Oulu University Hospital, Internal Medicine Research Unit

相似试验